Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (45 ops.)
Latest filing published 15 May 2026 for Karyopharm Therapeutics Inc..
Filing timeline
BuySaleRichard A. Paulson
Insider track record
Disclosed buys
0
Disclosed sells
45
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard A. Paulson: trading record in brief
This profile gathers the share dealings of Richard A. Paulson across 2 companies, led by Karyopharm Therapeutics Inc. and bluebird bio, Inc. We count 59 filings; the first trade dates from 3 May 2021 and the latest from 13 May 2026.
Every open-market trade on record is a sale: 45 sales worth €795k. Other entries cover 12 share grants. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 15 May 2026, reports a share grant in Karyopharm Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard A. Paulson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
4,920 shares0Common StockSEC:0001193125-26-226613:0
12,361 shares@ US$9.409520.2% of flowCommon StockSEC:0001804460-26-000003:0
81,060 shares0Common StockSEC:0001193125-26-042799:0
114,285 shares0Common StockSEC:0001193125-25-241471:0
2,800 shares0Common StockSEC:0001193125-25-205052:0
155 sharesCommon StockSEC:0000950170-25-081108:0
236 shares@ US$7.120.4% of flowCommon StockSEC:0000950170-25-065884:0
245 shares@ US$3.740.2% of flowCommon StockSEC:0000950170-25-051658:0
11,694 shares@ US$6.2917.9% of flowCommon StockSEC:0000950170-25-034736:0
20,000 shares0Common StockSEC:0000950170-25-032297:0
4,099 shares@ US$0.650.7% of flowCommon StockSEC:0000950170-25-014491:0
4,055 shares@ US$0.7830.8% of flowCommon StockSEC:0000950170-25-002819:0
3,620 shares@ US$0.810.7% of flowCommon StockSEC:0000950170-24-133689:0
24,900 shares0Common StockSEC:0001562180-24-007607:0
3,675 shares@ US$0.91060.8% of flowCommon StockSEC:0000950170-24-122274:0
3,607 shares@ US$0.87930.7% of flowCommon StockSEC:0000950170-24-113263:0
3,667 shares@ US$0.72180.6% of flowCommon StockSEC:0000950170-24-104033:0
3,608 shares@ US$0.92990.8% of flowCommon StockSEC:0000950170-24-094087:0
3,616 shares@ US$0.8510.7% of flowCommon StockSEC:0000950170-24-082417:0
3,592 shares@ US$0.990.8% of flowCommon StockSEC:0000950170-24-069856:0
3,576 shares@ US$1.131.0% of flowCommon StockSEC:0000950170-24-054686:0
3,563 shares@ US$1.291.1% of flowCommon StockSEC:0000950170-24-042350:0
3,573 shares@ US$1.301.1% of flowCommon StockSEC:0000950170-24-027153:0
80,470 shares@ US$1.1722.2% of flowCommonSEC:0000950170-24-025188:0
442,800 shares0Common StockSEC:0000950170-24-023281:0
25 of 52 declarations
